Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1994-5-16
pubmed:abstractText
Antisense oligonucleotides have proved effective in achieving targeted inhibition of gene expression. In such experiments, sense oligonucleotides have frequently been used as a control for nonspecific effects, but the results have been variable, raising questions about the reliability of sense oligomers as a control. It is possible that some of the effects of sense oligonucleotides may be specific. We have shown that phosphorothioate antisense oligonucleotides to the p65 subunit of NF-kappa B, a transcription factor, cause a block in cell adhesion. In our efforts to test the efficacy of NF-kappa B p65 oligonucleotides in vivo, we unexpectedly observed that the control p65-sense, but not the p65-antisense, oligonucleotides caused massive splenomegaly in mice. In the current study we demonstrate a sequence-specific stimulation of splenic cell proliferation, both in vivo and in vitro, by treatment with p65-sense oligonucleotides. Cells expanded by this treatment are primarily B-220+, sIg+ B cells. The secretion of immunoglobulins by the p65-sense oligonucleotide-treated splenocytes is also enhanced. In addition, the p65-sense-treated splenocytes, but not several other cell lines, showed an upregulation of NF-kappa B-like activity in the nuclear extracts, an effect not dependent on new protein or RNA synthesis. These results demonstrate that phosphorothioate oligonucleotides can exert sequence-specific effects in vivo, irrespective of sense or antisense orientation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1050-5261
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
309-22
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:8155973-Animals, pubmed-meshheading:8155973-B-Lymphocytes, pubmed-meshheading:8155973-Base Sequence, pubmed-meshheading:8155973-Binding Sites, pubmed-meshheading:8155973-Cell Adhesion, pubmed-meshheading:8155973-Cell Division, pubmed-meshheading:8155973-Cells, Cultured, pubmed-meshheading:8155973-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:8155973-Flow Cytometry, pubmed-meshheading:8155973-Immunoglobulin G, pubmed-meshheading:8155973-Immunoglobulin M, pubmed-meshheading:8155973-Lymphocyte Activation, pubmed-meshheading:8155973-Mice, pubmed-meshheading:8155973-Mice, Inbred C57BL, pubmed-meshheading:8155973-Molecular Sequence Data, pubmed-meshheading:8155973-NF-kappa B, pubmed-meshheading:8155973-Oligodeoxyribonucleotides, pubmed-meshheading:8155973-Spleen, pubmed-meshheading:8155973-Splenomegaly, pubmed-meshheading:8155973-Thionucleotides, pubmed-meshheading:8155973-Up-Regulation
pubmed:year
1993
pubmed:articleTitle
A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation.
pubmed:affiliation
Department of Inflammation/Autoimmune Diseases, Roche Research Center, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110.
pubmed:publicationType
Journal Article